myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial kit (642V64=T)
Otto Bock Healthcare Products GmbH · Decision date Apr 22, 2026
What did the FDA decide?
FDA records K253256 as a 510(k) premarket notification, with a decision dated Apr 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Apr 22, 2026
Regulatory record facts
- Identifier
- K253256
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Otto Bock Healthcare Products GmbH
- Product code
- GXY
- Decision code
- SESE
- Decision date
- Apr 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Electrode, Cutaneous.
- Applicant
- Otto Bock Healthcare Products GmbH
- Product code
- GXY
- FDA device class
- 2
FDA decision timeline
K253256 received
Application receipt date recorded by FDA.
K253256 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GXY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bionit Labs Srl | 510(k) clearance | Nov 6, 2026 | FDA | |
BioWave BioWrapsK263666 | Biowave Corporation | 510(k) clearance | Nov 5, 2026 | FDA |
| Bozhou Rongjian Medical Appliance Co., Ltd. | 510(k) clearance | Oct 20, 2026 | FDA | |
| Zhejiang Qiangnao Technology Co.,Ltd | 510(k) clearance | Aug 27, 2026 | FDA | |
| Ambu A/S | 510(k) clearance | Jul 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Otto Bock Healthcare Products GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Vienna
Sources and methodology
- Original FDA record: K253256
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


